INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING MULTIPLE MYELOMA WITH BISPECIFIC BCMA X CD3 ANTIBODIES"

GENEVA, Dec. 2 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/029942) for "METHODS OF TREATING MULTIPLE MYELOMA WITH BISPECIFIC BCMA X CD3 ANTIBODIES" on May 19, 2025. With publication no. WO/2025/244973, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KROOG, Glenn (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591)

Abstract: The present disclosure provides methods for treating multiple myeloma. In cert...